Berinstein N - Search Results

1

Risk-adapted therapy for clinical stage I-II Hodgkin's disease: 7-years results of radiotherapy alone for low-risk disease, and ABVD and radiotherapy for high-risk disease.

MacKenzie RG, Franssen E, Wong R, Sawka C, Berinstein N, Cowan DH, Senn J, Poldre P. MacKenzie RG, et al. Among authors: berinstein n. Clin Oncol (R Coll Radiol). 2000;12(5):278-88. doi: 10.1053/clon.2000.9174. Clin Oncol (R Coll Radiol). 2000. PMID: 11315710

2

Mitoxantrone-DHAP with GM-CSF: an active but myelosuppressive salvage therapy for relapsed/refractory aggressive non-Hodgkin's lymphoma.

Haq R, Sawka CA, Franssen E, Berinstein NL. Haq R, et al. Among authors: berinstein nl. Leuk Lymphoma. 1999 Nov;35(5-6):527-36. doi: 10.1080/10428199909169617. Leuk Lymphoma. 1999. PMID: 10609790 Clinical Trial.

3

Significance of a partial or slow response to front-line chemotherapy in the management of intermediate-grade or high-grade non-Hodgkin's lymphoma: a literature review.

Haw R, Sawka CA, Franssen E, Berinstein NL. Haw R, et al. Among authors: berinstein nl. J Clin Oncol. 1994 May;12(5):1074-84. doi: 10.1200/JCO.1994.12.5.1074. J Clin Oncol. 1994. PMID: 8164032

4

Delivery of full dose CHOP chemotherapy to elderly patients with aggressive non-Hodgkin's lymphoma without G-CSF support.

Campbell C, Sawka C, Franssen E, Berinstein NL. Campbell C, et al. Among authors: berinstein nl. Leuk Lymphoma. 1999 Sep;35(1-2):119-27. doi: 10.3109/10428199909145711. Leuk Lymphoma. 1999. PMID: 10512169

5

Primary Hodgkin's disease of the CNS in an immunocompetent patient: a case study and review of the literature.

Biagi J, MacKenzie RG, Lim MS, Sapp M, Berinstein N. Biagi J, et al. Among authors: berinstein n. Neuro Oncol. 2000 Oct;2(4):239-43. doi: 10.1093/neuonc/2.4.239. Neuro Oncol. 2000. PMID: 11265233 Free PMC article.

6

Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early-stage and advanced-stage follicular lymphoma.

Berinstein NL, Reis MD, Ngan BY, Sawka CA, Jamal HH, Kuzniar B. Berinstein NL, et al. J Clin Oncol. 1993 Jul;11(7):1344-52. doi: 10.1200/JCO.1993.11.7.1344. J Clin Oncol. 1993. PMID: 8315432

7

Sequence preservation of the third exon of the bcl-2 gene in non-Hodgkin's lymphoma: absence of somatic hypermutation.

Farrugia MM, Duan LJ, Reis MD, Ngan BY, Sawka CA, Berinstein NL. Farrugia MM, et al. Among authors: berinstein nl. Leukemia. 1995 Apr;9(4):643-9. Leukemia. 1995. PMID: 7723399

8

Spontaneous regression of Hodgkin's disease: two case reports and a review of the literature.

Mangel J, Barth D, Berinstein NL, Imrie KR. Mangel J, et al. Among authors: berinstein nl. Hematology. 2003 Jun;8(3):191-6. doi: 10.1080/1024533031000107514. Hematology. 2003. PMID: 12745644 Free article. Review.

9

Pharmacokinetic study of patients with follicular or mantle cell lymphoma treated with rituximab as 'in vivo purge' and consolidative immunotherapy following autologous stem cell transplantation.

Mangel J, Buckstein R, Imrie K, Spaner D, Franssen E, Pavlin P, Boudreau A, Pennell N, Combs D, Berinstein NL. Mangel J, et al. Among authors: berinstein nl. Ann Oncol. 2003 May;14(5):758-65. doi: 10.1093/annonc/mdg201. Ann Oncol. 2003. PMID: 12702531 Free article. Clinical Trial.

10

T-cell analysis in identical twins reveals an impaired anti-follicular lymphoma immune response in the patient but not in the healthy twin.

Gitelson E, Spaner D, Buckstein R, Franssen E, Hewitt K, Lim MS, Pennell N, Schultze JL, Berinstein NL. Gitelson E, et al. Among authors: berinstein nl. Br J Haematol. 2002 Jan;116(1):122-7. doi: 10.1046/j.1365-2141.2002.03240.x. Br J Haematol. 2002. PMID: 11841404 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters